Announced Wed, 29 Apr · 17:30 IST
Promoters Confirm No Share Encumbrance for FY2026
Compliance View source PDF
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹1095.95
prior close
₹1093.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.4+0.2+1.1+2.1+3.4+4.7+5.4+7.2+7.7+6.8-14.7-15.0—
Up moveDown movePending
AI summary
Natco Pharma's promoter V.C. Nannapaneni has filed a SEBI Regulation 31(4) disclosure confirming that shares held by him, other promoters, promoter group members, and persons acting in concert were not encumbered or pledged during the financial year ended March 31, 2026. This is a routine annual compliance filing.
Likely market impact
Positive — promoters' shares remain unpledged, reducing forced-selling risk and signaling confidence in the company.